Comparative effectiveness of bivalent BA.4-5 and BA.1 mRNA booster vaccines among adults aged ≥50 years in Nordic countries: nationwide cohort study

OBJECTIVE: To estimate the effectiveness of the bivalent mRNA booster vaccines containing the original SARS-CoV-2 and omicron BA.4-5 or BA.1 subvariants as the fourth dose against severe covid-19. DESIGN: Nationwide cohort analyses, using target trial emulation. SETTING: Denmark, Finland, Norway, an...

Descripción completa

Detalles Bibliográficos
Autores principales: Andersson, Niklas Worm, Thiesson, Emilia Myrup, Baum, Ulrike, Pihlström, Nicklas, Starrfelt, Jostein, Faksová, Kristýna, Poukka, Eero, Meijerink, Hinta, Ljung, Rickard, Hviid, Anders
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group Ltd. 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10364194/
https://www.ncbi.nlm.nih.gov/pubmed/37491022
http://dx.doi.org/10.1136/bmj-2022-075286

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10364194/
https://www.ncbi.nlm.nih.gov/pubmed/37491022
http://dx.doi.org/10.1136/bmj-2022-075286

Ejemplares similares